Association of high-sensitivity cardiac troponin t and natriuretic peptide with incident ESRD: The atherosclerosis risk in communities (ARIC) study

American Journal of Kidney Diseases

Volumn 65, Issue 4, 2015, Pages 550-558

  Kim, Yuhree ^a   Matsushita, Kunihiro ^a   Sang, Yingying ^a   Grams, Morgan E ^a,b   Skali, Hicham ^c   Shah, Amil M ^c   Hoogeveen, Ron C ^d,e   Solomon, Scott D ^c   Ballantyne, Christie M ^d,e   Coresh, Josef ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis Risk in Communities (ARIC) Study.; cardiac injury; cardiac marker; High sensitivity cardiac troponin T (hs cTnT); incident end stage renal disease (ESRD); kidney disease progression; N terminal probrain natriuretic peptide (NTproBNP); risk factor; risk prediction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; BLACK PERSON; BLOOD; CARDIAC MUSCLE; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; INCIDENCE; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BIOMARKERS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 84926296822     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.08.021     Document Type: Article

References (50)

1. C. Ronco, M. Haapio, A.A. House, N. Anavekar, and R. Bellomo Cardiorenal syndrome J Am Coll Cardiol 52 19 2008 1527 1539
2. C. Ronco, A.A. House, and M. Haapio Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus Nat Clin Pract Nephrol 4 6 2008 310 311
3. T. Berl, and W. Henrich Kidney-heart interactions: epidemiology, pathogenesis, and treatment Clin J Am Soc Nephrol 1 1 2006 8 18
4. J.S. Bock, and S.S. Gottlieb Cardiorenal syndrome: new perspectives Circulation 121 23 2010 2592 2600
5. A. Whaley-Connell, and J.R. Sowers Oxidative stress in the cardiorenal metabolic syndrome Curr Hypertens Rep 14 4 2012 360 365
6. P.C. Colombo, A. Ganda, and J. Lin Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome Heart Fail Rev 17 2 2012 177 190
7. I. Muhlberger, K. Monks, and R. Fechete Molecular pathways and crosstalk characterizing the cardiorenal syndrome OMICS 16 3 2012 105 112
8. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
9. J.D. Harnett, R.N. Foley, G.M. Kent, P.E. Barre, D. Murray, and P.S. Parfrey Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 3 1995 884 890
10. K. Matsushita, M. van der Velde, and B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
11. F.A. McAlister, J. Ezekowitz, M. Tonelli, and P.W. Armstrong Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 8 2004 1004 1009
12. E. Paoletti, D. Bellino, A.M. Gallina, M. Amidone, P. Cassottana, and G. Cannella Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant 26 2 2011 670 677
13. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 17 2003 2154 2169
14. D.E. Weiner, H. Tighiouart, and M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 5 2004 1307 1315
15. S.C. Chen, H.M. Su, and C.C. Hung Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease Clin J Am Soc Nephrol 6 12 2011 2750 2758
16. E.F. Elsayed, H. Tighiouart, and J. Griffith Cardiovascular disease and subsequent kidney disease Arch Intern Med 167 11 2007 1130 1136
17. A.S. Desai, R. Toto, and P. Jarolim Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD Am J Kidney Dis 58 5 2011 717 728
18. J.T. Saunders, V. Nambi, and J.A. de Lemos Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study Circulation 123 13 2011 1367 1376
19. H. Eriksson, K. Caidahl, and B. Larsson Cardiac and pulmonary causes of dyspnoea - validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913 Eur Heart J 8 9 1987 1007 1014
20. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
21. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int 3 1 2013
22. K. Matsushita, B.K. Mahmoodi, and M. Woodward Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration rate JAMA 307 18 2012 1941 1951
23. C. van Walraven, D.G. Manuel, and G. Knoll Survival trends in ESRD patients compared with the general population in the United States Am J Kidney Dis 63 3 2014 491 499
24. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 10 2008 933 989
25. N. Tangri, L.A. Stevens, and J. Griffith A predictive model for progression of chronic kidney disease to kidney failure JAMA 305 15 2011 1553 1559
26. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
27. M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2009 2019 2032
28. A. Nohria, V. Hasselblad, and A. Stebbins Cardiorenal interactions: insights from the ESCAPE trial J Am Coll Cardiol 51 13 2008 1268 1274
29. G. Remuzzi, N. Perico, M. Macia, and P. Ruggenenti The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease Kidney Int Suppl 99 2005 S57 S65
30. S. Mezzano, A. Droguett, and M.E. Burgos Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy Kidney Int Suppl 86 2003 S64 S70
31. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexander Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 74 6 1994 1141 1148
32. L. Stojiljkovic, and R. Behnia Role of renin angiotensin system inhibitors in cardiovascular and renal protection: a lesson from clinical trials Curr Pharm Des 13 13 2007 1335 1345
33. Y. Iwanaga, and S. Miyazaki Heart failure, chronic kidney disease, and biomarkers - an integrated viewpoint Circ J 74 7 2010 1274 1282
34. P.J. O'Brien, G.W. Dameron, and M.L. Beck Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals Lab Anim Sci 47 5 1997 486 495
35. S.F. Peek, F.S. Apple, M.A. Murakami, P.M. Crump, and S.D. Semrad Cardiac isoenzymes in healthy Holstein calves and calves with experimentally induced endotoxemia Can J Vet Res 72 4 2008 356 361
36. X. Bosch, E. Poch, and J.M. Grau Rhabdomyolysis and acute kidney injury N Engl J Med 361 1 2009 62 72
37. M.S. Edwards, D.B. Wilson, and T.E. Craven Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study Am J Kidney Dis 46 2 2005 214 224
38. R.T. Dadu, M. Fornage, and S.S. Virani Cardiovascular biomarkers and subclinical brain disease in the Atherosclerosis Risk in Communities Study Stroke 44 7 2013 1803 1808
39. J. Rubin, K. Matsushita, C.M. Ballantyne, R. Hoogeveen, J. Coresh, and E. Selvin Chronic hyperglycemia and subclinical myocardial injury J Am Coll Cardiol 59 5 2012 484 489
40. J.C. Kaski Overview of gender aspects of cardiac syndrome X Cardiovasc Res 53 3 2002 620 626
41. S.E. Reis, R. Holubkov, and A.J. Conrad Smith Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE Study Am Heart J 141 5 2001 735 741
42. H.M. Arthur, P. Campbell, and P.J. Harvey Women, cardiac syndrome X, and microvascular heart disease Can J Cardiol 28 2 Suppl 2012 S42 S49
43. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, and G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 14 2010 1071 1078
44. R.T. Dadu, V. Nambi, and C.M. Ballantyne Developing and assessing cardiovascular biomarkers Translat Res 159 4 2012 265 276
45. T. Nishikimi, N. Maeda, and H. Matsuoka The role of natriuretic peptides in cardioprotection Cardiovasc Res 69 2 2006 318 328
46. S.U. Nigwekar, S.D. Navaneethan, C.R. Parikh, and J.K. Hix Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis Clin J Am Soc Nephrol 4 2 2009 261 272
47. A.B. Ropero, S. Soriano, and E. Tuduri The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function Endocrinology 151 8 2010 3665 3674
48. G.K. Kapuku, H.C. Davis, P. Thomas, J. Januzzi, and G.A. Harshfield Does the relationship between natriuretic hormones and diastolic function differ by race? Am J Med Sci 344 2 2012 96 99
49. Centers for Medicare and Medicaid Services. National health expenditures 2011 highlights. 2012. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/highlights.pdf. Accessed April 1, 2013.
50. B.R. Hemmelgarn, M.T. James, and B.J. Manns Rates of treated and untreated kidney failure in older vs younger adults JAMA 307 23 2012 2507 2515